Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
NCT00275613
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Glomerulonephritis, Membranoproliferative
Interventions
DRUG:
Rituximab
Sponsor
Mayo Clinic